ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Lannett Company Inc

Lannett Company Inc (LCI)

0.6855
0.00
( 0.00% )
업데이트: 09:00:00

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

주요 통계 및 세부정보

가격
0.6855
매수가
-
매도가
-
거래량
-
0.00 일간 변동폭 0.00
0.00 52주 범위 0.00
전일 종가
0.6855
개장가
-
최근 거래 시간
마지막 거래 시간
-
평균 볼륨(3m)
-
재정 규모
-
VWAP
-

LCI 최신 뉴스

Lannett Company, Inc. Enters Into Restructuring Support Agreement

Lannett Company, Inc. Enters Into Restructuring Support Agreement PR Newswire TREVOSE, Pa., May 1, 2023 Restructuring Support Agreement Supported by Holders of More Than 80% of the Company's...

NYSE TO SUSPEND TRADING IMMEDIATELY IN LANNETT COMPANY, INC. (LCI) AND COMMENCE DELISTING PROCEEDINGS

NYSE TO SUSPEND TRADING IMMEDIATELY IN LANNETT COMPANY, INC. (LCI) AND COMMENCE DELISTING PROCEEDINGS PR Newswire TREVOSE, Pa., April 20, 2023 Company Expects No Impact on Operations Negotiations...

LANNETT SHARES UPDATE

LANNETT SHARES UPDATE PR Newswire TREVOSE, Pa., April 4, 2023 Announces Positive Results from Pivotal Clinical Insulin Trial that Demonstrates Biosimilarity to Reference Product Productive...

LANNETT REPORTS IMPROVED FISCAL 2023 SECOND QUARTER FINANCIAL RESULTS; RAISES FULL-YEAR GUIDANCE

LANNETT REPORTS IMPROVED FISCAL 2023 SECOND QUARTER FINANCIAL RESULTS; RAISES FULL-YEAR GUIDANCE PR Newswire TREVOSE, Pa., Feb. 1, 2023 Q2 Business and Financial Highlights: Net Sales were $80.9...

LANNETT ANNOUNCES 1 FOR 4 REVERSE STOCK SPLIT

LANNETT ANNOUNCES 1 FOR 4 REVERSE STOCK SPLIT PR Newswire TREVOSE, Pa., Jan. 25, 2023 TREVOSE, Pa., Jan. 25, 2023 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that its Board...

LANNETT TO REPORT FISCAL 2023 SECOND-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, FEBRUARY 1

LANNETT TO REPORT FISCAL 2023 SECOND-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, FEBRUARY 1 PR Newswire TREVOSE, Pa., Jan. 25, 2023 TREVOSE, Pa., Jan. 25, 2023 /PRNewswire/...

LANNETT PROVIDES DEVELOPMENT UPDATE ON BIOSIMILAR INSULIN PRODUCTS

LANNETT PROVIDES DEVELOPMENT UPDATE ON BIOSIMILAR INSULIN PRODUCTS PR Newswire TREVOSE, Pa., Jan. 4, 2023 --Announces Positive Animal PK Study Results of Insulin Aspart Versus US...

LANNETT ANNOUNCES PATENT LICENSES FOR THE PEN INJECTOR DELIVERY DEVICE TO BE USED FOR ITS INSULIN GLARGINE AND INSULIN ASPART DEVELOPMENT PROGRAM

LANNETT ANNOUNCES PATENT LICENSES FOR THE PEN INJECTOR DELIVERY DEVICE TO BE USED FOR ITS INSULIN GLARGINE AND INSULIN ASPART DEVELOPMENT PROGRAM PR Newswire TREVOSE, Pa., Nov. 7, 2022 TREVOSE...

LANNETT REPORTS BETTER THAN EXPECTED FINANCIAL RESULTS FOR FISCAL 2023 FIRST-QUARTER; REITERATES FULL-YEAR GUIDANCE

LANNETT REPORTS BETTER THAN EXPECTED FINANCIAL RESULTS FOR FISCAL 2023 FIRST-QUARTER; REITERATES FULL-YEAR GUIDANCE PR Newswire TREVOSE, Pa., Nov. 2, 2022 Q1 Business and Financial...

LANNETT TO REPORT FISCAL 2023 FIRST-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, NOVEMBER 2

LANNETT TO REPORT FISCAL 2023 FIRST-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, NOVEMBER 2 PR Newswire TREVOSE, Pa., Oct. 26, 2022 TREVOSE, Pa., Oct. 26, 2022 /PRNewswire/...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
CTVInnovid Corp
US$ 3.015
(86.11%)
46.74M
SNOWSnowflake Inc
US$ 172.53
(33.62%)
39.73M
LEVLion Electric Company
US$ 0.2443
(29.95%)
4.92M
ODVOsisko Development Corporation
US$ 1.9199
(29.72%)
1.56M
SRFMSurf Air Mobility Inc
US$ 2.55
(24.39%)
468.21k
CATOCato Corp
US$ 4.95
(-18.59%)
143.67k
KLCKindercare Learning Companies Inc
US$ 19.48
(-14.56%)
863.51k
ZIMZIM Integrated Shipping Services Ltd
US$ 23.755
(-12.05%)
10.02M
CLCOCool Company LTD
US$ 9.3732
(-11.91%)
1.57M
CPACCementos Pacasmayo SAA New
US$ 5.78
(-11.62%)
15.85k
CTVInnovid Corp
US$ 3.015
(86.11%)
46.74M
SNOWSnowflake Inc
US$ 172.53
(33.62%)
39.73M
PLTRPalantir Technologies Inc
US$ 61.42
(-1.13%)
37.61M
NIONIO Inc
US$ 4.705
(1.18%)
36.24M
IONQIonQ Inc
US$ 32.0397
(11.02%)
29.99M

LCI Discussion

게시물 보기
NASDAQ2020 NASDAQ2020 9 월 전
Buh Bye LMFAO !!!!
👍️0
NASDAQ2020 NASDAQ2020 9 월 전
Your a DA
👍️0
NASDAQ2020 NASDAQ2020 1 년 전
KIRKOV HAMMERTIME !!!
👍️0
NASDAQ2020 NASDAQ2020 1 년 전
HammerTime !!!
👍️ 1
IB_ IB_ 1 년 전
Lannett, The King is Dead !!!!

Hey Thanks A Lot aLmA,

IB_
👍️0
IB_ IB_ 1 년 전
I guess its over ............................................

Today,

Hey Thanks A Lot For Your Service aLmA,

IB_
👍️0
Jimmy Joe Jimmy Joe 1 년 전
Elite is not next. Elite is too well run. The balance sheet is also too good. Cash on hand exceeds LTD. Naked shorted Elite too~? LOL~!

NEXT~!
👍️ 1
jbdiver jbdiver 1 년 전
Lol… hope you had your whole ira in on it. I’ll buy the rope for you
👍️0
jbdiver jbdiver 1 년 전
Buh bye… lol

Unelite is next! Ciao baby! Lol
👍️0
splintered sunlight splintered sunlight 1 년 전
Glad I was able to dump this turd.
👍️0
NASDAQ2020 NASDAQ2020 1 년 전
RIP LCI

There's a New kid on the block
👍️0
Renee Renee 1 년 전
LCINQ: BK PLAN effective. All shares cancelled.

https://otce.finra.org/otce/dailyList?viewType=Deletions
👍️0
splintered sunlight splintered sunlight 1 년 전
Yes

I myself have moved on - if it gets activeI'lll take another look.
👍️0
hondaboost hondaboost 1 년 전
Seems people have no interest in it.
👍️0
splintered sunlight splintered sunlight 1 년 전
And the pop is over.
👍️0
splintered sunlight splintered sunlight 1 년 전
Got a pop today.
👍️0
hondaboost hondaboost 2 년 전
CEO, CFO, COO, insiders bought millions of shares at $0.5. LOL!
👍️0
hondaboost hondaboost 2 년 전
LCINQ, $0.019? O/S: 10 m. Cash: $55 m, $5.5/share; Assets: $438 Million, or $43.8 m/share. Vast! Now, $0.019 ???. Extremely undervalued!!!

https://www.otcmarkets.com/filing/html?id=16359583&guid=C2u-kn8hn_cHJth

Did 4 for 1 RS in Feb. O/S: 10 M.

It was high as $3.7 a while ago!
👍️0
Jimmy Joe Jimmy Joe 2 년 전
jbdiver still waiting for the other shoe to drop~? Are you short something~?

Lannett an older company. Will truly be sorry to see it go. Hopefully someone comes in to buy them.

One company has nothing to do with the other. Management always rises to the top or sinks to the bottom.
In Pharmaceuticals, unlike other industries/sectors things metastasize at a much slower rate. NDAs, ANDAs, R&D all take years. Compliance is another issue and often times the people you surround your company with ensure success or failure.

Attracting the best talent for the company is another problem. AND experienced leadership is the KEY. Something many antsy investors miss.

All it takes is one missed opportunity, a compliance issue, or losing valued talent that kept the company viable for decades. An iconic company gone. Sincerely sorry to see Lannett this way.

JB Diver, I do wish you all the best. The lack of understanding is unreal. You and Ama need to form a book club.
👍️ 1
splintered sunlight splintered sunlight 2 년 전
Thank you
👍️0
jbdiver jbdiver 2 년 전
They are a another nobody otc company which has convinced investors out of hard earned money and creates loser partnerships with companies like Lannett.

Thats Unelite Pharma in a nutshell.
👍️0
Renee Renee 2 년 전
Effective May 4,2023 LCIN will change to LCINQ, bankruptcy.

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
👍️0
Jimmy Joe Jimmy Joe 2 년 전
So how's LCI's stock price Ama~? Did it squeeze for you~? No~?

Make Lannett Great Again
How's that one~?

See, could have had a CEO like this one leading Elite. Which company has a better balance sheet ~?........ Elite. Which CEO is head and shoulders above the other~? Nasrat for sure.

That's the pharma biz though. Only takes a drug or two to take ya down. One bad decision and KA-POW~!
👍️ 1
splintered sunlight splintered sunlight 2 년 전
What id unelite?
👍️0
jbdiver jbdiver 2 년 전
Good old fashion fire sale!
👍️0
jbdiver jbdiver 2 년 전
Hey Unelite Rah Rah’s.

Tell me again how great a RS will be for Unelite?!

Hahaaaaaaaaaa

Take a picture of today. There will be a repeat of this at Unelite. No one should have there surprise faces on when it happens.
👍️0
jbdiver jbdiver 2 년 전
Just saw this one!


Hahaaaaaaaaaaaaa

Its exploding alright. Front row ticket to the apocolypse
👍️0
splintered sunlight splintered sunlight 2 년 전
Why?
👍️0
The ELTP King The ELTP King 2 년 전
Done is an understatement.

I know they were delisted - are they done?
👍️0
splintered sunlight splintered sunlight 2 년 전
What happened here?

I know they were delisted - are they done?

thanks
👍️0
splintered sunlight splintered sunlight 2 년 전
Seriously.

WTF??????
👍️0
NASDAQ2020 NASDAQ2020 2 년 전
LCI rest in peace
👍️0
splintered sunlight splintered sunlight 2 년 전
They are hammering it!!!!
👍️0
splintered sunlight splintered sunlight 2 년 전
The way the stock acts. it's too late - the selling is relentless.
👍️0
NASDAQ2020 NASDAQ2020 2 년 전
They need a CEO like Nasrat Hakim, or is it too late to save ?
👍️0
The ELTP King The ELTP King 2 년 전
Hahahahahahahahahaha!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

Lci is fine their problem is their crappy partner elite


------------------------------------------------------------------------------------------------------------------------------------------
👍️0
The ELTP King The ELTP King 2 년 전
Hahahahahahahahahaha!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

Stock up sharply. Great entry spot.

------------------------------------------------------------------------------------------------------------------------------------------
👍️0
The ELTP King The ELTP King 2 년 전
Hahahahahahahahahaha!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

This could turn out to be a nice squeeze play.

Putting this on my watch list with some others.

$LCI will be in play here. Buckle up soon.


------------------------------------------------------------------------------------------------------------------------------------------
👍️0
AtlSteel AtlSteel 2 년 전
Its trading as LCIN on the pink sheets.
👍️ 1
splintered sunlight splintered sunlight 2 년 전
What the hell - LCIN getting crushed!!!!!!!!

Down 64%
👍️0
NASDAQ2020 NASDAQ2020 2 년 전
NYSE to Suspend Trading Immediately in Lannett Company, Inc. (LCI) and Commence Delisting Proceedings

April 19, 2023, 4:30 PM EDT
NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Lannett Company, Inc. (the “Company”) - ticker symbol LCI - from the NYSE. Trading in the Company’s common stock will be suspended immediately.

NYSE Regulation reached its decision to delist the Company’s common stock pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s continued listing standard requiring listed companies to maintain an average global market capitalization over a consecutive 30 trading day period of at least $15,000,000.

The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the common stock upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.
👍️ 1
NASDAQ2020 NASDAQ2020 2 년 전
LCI: SENATE BILL TO STREAMLINE GENERIC DRUG APPROVAL REINTRODUCED
SA Breaking News
👍️ 1
NASDAQ2020 NASDAQ2020 2 년 전
LCI losing some good partners
👍️ 1
Sierra20 Sierra20 2 년 전
Positive data on insulin glargine coming. Will totally change the trajectory for LCI.
👍️ 1
NASDAQ2020 NASDAQ2020 2 년 전
HammerTime !!!!!!!!!!!!!!!!!!!!!!!!!!!!
👍️ 1
harry crumb harry crumb 2 년 전
Sorry supposed to be 7 not 6th lol
👍️0
harry crumb harry crumb 2 년 전
1/4 RS effective feb 6
👍️0
TrendTrade2016 TrendTrade2016 2 년 전
LCI...READY TO RUMBLE
👍️0
cuggegrosse cuggegrosse 2 년 전
Any ideas why the jump at 0.90 yesterday???? Serious replys appriciated
👍️ 1
sharkey1 sharkey1 2 년 전
I may have to lower my expectations for our fin's on nov.14












Three Months Ended


(In thousands)


September 30,


Medical Indication



2022



2021


Analgesic


$

3,424


$

5,314


Anti-Psychosis



2,620



3,715


Cardiovascular




10,882




14,100


Central Nervous System



20,794



22,785


Endocrinology



7,312



7,845


Gastrointestinal



7,942



15,240


Infectious Disease



5,069



12,515


Migraine




3,324




4,685


Respiratory/Allergy/Cough/Cold



1,202



3,114


Other




8,759




10,352


Contract manufacturing revenue



3,751



1,860


Total net sales


$

75,079


$

101,525
👍️0